Bronchopulmonary Dysplasia Care: Evidence-Based, Future Focused
Bronchopulmonary Dysplasia Care: Evidence-Based, Future Focused https://pediatricsnationwide.org/wp-content/uploads/2026/04/W1909850-Rsrch_PedsNW-SpringSummer2026_Pg-24-header-1024x448.jpg 1024 448 Nationwide Children's https://secure.gravatar.com/avatar/98a5f893feafa2a2d0490fcad44e5df9a4365ffbe43419b0bffd82d28598dc4e?s=96&d=mm&r=g
Bronchopulmonary dysplasia (BPD), also known as chronic lung disease, causes long-term breathing problems for premature babies, often resulting in poor growth and development.
The team at the Comprehensive Center for Bronchopulmonary Dysplasia at Nationwide Children’s saves babies from around the world with the most severe cases of BPD. As a result of being leaders in cutting-edge research, innovative treatment approach and one-of-a-kind facility, patients have:
- A 99% survival rate
- Shorter hospital stays
- Fewer readmissions
Learn more about BPD research and care through the stories below. For more, search BPD from the homepage.
A national leader in bronchopulmonary dysplasia (BPD) care, Nationwide Children’s is home to the only dedicated BPD unit in the United States. As a founding member of the BPD Collaborative, which includes more than 25 health care organizations focused on improving outcomes for BPD patients, the team is committed to sharing its expertise to advance care for babies everywhere. Team is available 24/7 to answer peer questions and provide consultations.